• Japanese
  • Korean
  • Chinese
Home > Publishers > La Merie Publishing
Publisher
Filter

La Merie Publishing Report List

La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company. The focus of our reports and subscription services such as databases and periodicals is directed towards biologs as therapeutics, such as antibodies, proteins, peptides, vaccines and biosimilars. Today we continue to publish reports, but leverage our experience, knowledge and report writing expertise to offer this service to individual customers.

Filter
Title Search
1 - 25 of 27 Products Sort by Display
*
Published by
La Merie Publishing
Product code
359751
Published
June 9, 2016
Content info
 
Price
USD 3500
Sample available
*
Published by
La Merie Publishing
Product code
318570
Published
annual subscription
Content info
 
Price
USD 1000
Sample available
*
Published by
La Merie Publishing
Product code
302689
Published
annual subscription
Content info
 
Price
USD 7565
Sample available
*
Published by
La Merie Publishing
Product code
276496
Published
annual subscription
Content info
1 Year Access to All Reports
Price
USD 5043
Sample available
*
Published by
La Merie Publishing
Product code
276495
Published
annual subscription
Content info
 
Price
USD 1600
Sample available
*
Published by
La Merie Publishing
Product code
276492
Published
annual subscription
Content info
 
Price
USD 7565
Sample available
*
Published by
La Merie Publishing
Product code
216725
Published
annual subscription
Content info
 
Price
USD 1261
Sample available
*
Published by
La Merie Publishing
Product code
166718
Published
annual subscription
Content info
 
Price
USD 1513
Sample available
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
Published by
La Merie Publishing
Product code
327820
Published
May 25, 2016
Content info
462 Pages
Price
USD 1450
Sample available
T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals
Published by
La Merie Publishing
Product code
357780
Published
May 11, 2016
Content info
230 Pages
Price
USD 2400
Sample available
Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - 2016 Update
Published by
La Merie Publishing
Product code
358307
Published
February 29, 2016
Content info
46 Pages
Price
USD 440
Sample available
RORgamma Modulators 2016: A Comparative Analysis of the Landscape of RORgamma Antagonists and Agonists
Published by
La Merie Publishing
Product code
351304
Published
February 3, 2016
Content info
88 Pages
Price
USD 1050
Sample available
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - A Pipeline, Technology, Stakeholder & Business Analysis
Published by
La Merie Publishing
Product code
294276
Published
November 30, 2015
Content info
470 Pages
Price
USD 2500
Sample available
Engineered TCR and CAR Immunotherapeutics 2015
Published by
La Merie Publishing
Product code
325905
Published
March 13, 2015
Content info
201 Pages
Price
USD 2630
Sample available
Recombinant Coagulation Factors 2015: Maturation of Recombinant Clotting Factor Pipeline and Emergence of Gene Therapy and Alternative Procoagulants
Published by
La Merie Publishing
Product code
274454
Published
December 22, 2014
Content info
210 Pages
Price
USD 2795
Sample available
Botulinum Neurotoxins: A Comparative Industry Analysis of Products, Pipelines, Technologies and Stakeholders
Published by
La Merie Publishing
Product code
308429
Published
July 18, 2014
Content info
169 Pages
Price
USD 2459
Sample available
Competitor Analysis: Cancer Vaccines
Published by
La Merie Publishing
Product code
221876
Published
March 24, 2014
Content info
179 Pages
Price
USD 1112
Sample available
*
Published by
La Merie Publishing
Product code
303587
Published
February 28, 2014
Content info
70 Pages
Price
USD 419
Sample available
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
Published by
La Merie Publishing
Product code
288582
Published
October 25, 2013
Content info
84 Pages
Price
USD 1829
Sample available
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Published by
La Merie Publishing
Product code
146105
Published
May 1, 2013
Content info
301 Pages
Price
USD 2018
Sample available
Influence of Antibody Attributes on Clinical Success - A Technology and Coporate Benchmark Analysis
Published by
La Merie Publishing
Product code
290176
Published
March 31, 2013
Content info
88 Pages
Price
USD 1135
Sample available
Antibody Technologies and Attrition Rates - An Industry Analysis 2013
Published by
La Merie Publishing
Product code
265036
Published
March 26, 2013
Content info
607 Pages
Price
USD 2711
Sample available
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012
Published by
La Merie Publishing
Product code
235119
Published
March 29, 2012
Content info
231 Pages
Price
USD 2459
Sample available
Competitor Analysis: Anti-Infective Antibodies
Published by
La Merie Publishing
Product code
224082
Published
November 21, 2011
Content info
160 Pages
Price
USD 505
Sample available
Coagulation Factors 2011 - Who Does Meet the Market Needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis
Published by
La Merie Publishing
Product code
224081
Published
October 31, 2011
Content info
162 Pages
Price
USD 2421
Sample available